{"title":"美国基因与细胞治疗学会第13届年会。","authors":"Gaetano Romano","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>The American Society of Gene & Cell Therapy's 13th Annual Meeting, held in Washington, DC, included topics covering new developments in the field of gene therapy. This conference report highlights selected presentations on adenoviral therapies for the treatment of cancer, HIV immunotherapies and gene/cell therapies for the treatment of genetic disorders. Investigational drugs discussed include the TAG vaccine and INGN-007 (both Gradalis Inc), AdCD40L (Uppsala University), Ad5-SSTR/TK-RGD (University of Alabama at Birmingham), CGTG-102 (Oncos Therapeutics Ltd) and lexgenleucel-T (VIRxSYS Corp).</p>","PeriodicalId":55031,"journal":{"name":"Idrugs","volume":"13 7","pages":"444-7"},"PeriodicalIF":0.0000,"publicationDate":"2010-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"American Society of Gene & Cell Therapy--13th Annual Meeting.\",\"authors\":\"Gaetano Romano\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The American Society of Gene & Cell Therapy's 13th Annual Meeting, held in Washington, DC, included topics covering new developments in the field of gene therapy. This conference report highlights selected presentations on adenoviral therapies for the treatment of cancer, HIV immunotherapies and gene/cell therapies for the treatment of genetic disorders. Investigational drugs discussed include the TAG vaccine and INGN-007 (both Gradalis Inc), AdCD40L (Uppsala University), Ad5-SSTR/TK-RGD (University of Alabama at Birmingham), CGTG-102 (Oncos Therapeutics Ltd) and lexgenleucel-T (VIRxSYS Corp).</p>\",\"PeriodicalId\":55031,\"journal\":{\"name\":\"Idrugs\",\"volume\":\"13 7\",\"pages\":\"444-7\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2010-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Idrugs\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Idrugs","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
American Society of Gene & Cell Therapy--13th Annual Meeting.
The American Society of Gene & Cell Therapy's 13th Annual Meeting, held in Washington, DC, included topics covering new developments in the field of gene therapy. This conference report highlights selected presentations on adenoviral therapies for the treatment of cancer, HIV immunotherapies and gene/cell therapies for the treatment of genetic disorders. Investigational drugs discussed include the TAG vaccine and INGN-007 (both Gradalis Inc), AdCD40L (Uppsala University), Ad5-SSTR/TK-RGD (University of Alabama at Birmingham), CGTG-102 (Oncos Therapeutics Ltd) and lexgenleucel-T (VIRxSYS Corp).
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
